These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16353673)

  • 21. 1,5-Anhydroglucitol × glycated hemoglobin A
    Su H; Ma X; Shen Y; He X; Ying L; Zhu W; Wang Y; Bao Y; Zhou J
    Acta Diabetol; 2020 Apr; 57(4):439-446. PubMed ID: 31728736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.
    Yamana A; Arita M; Furuta M; Shimajiri Y; Sanke T
    Diabetes Res Clin Pract; 2008 Oct; 82(1):127-31. PubMed ID: 18692932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes.
    Otsuka Y; Yamaguchi S; Furukawa A; Kosuda M; Nakazaki M; Ishihara H
    Endocr J; 2015; 62(2):133-43. PubMed ID: 25328079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical predictors and time course of the improvement in β-cell function with short-term intensive insulin therapy in patients with Type 2 diabetes.
    Stein CM; Kramer CK; Zinman B; Choi H; Opsteen C; Retnakaran R
    Diabet Med; 2015 May; 32(5):645-52. PubMed ID: 25495067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C.
    Shaefer C; Reid T; Vlajnic A; Zhou R; DiGenio A
    Endocr Pract; 2015 Dec; 21(12):1323-32. PubMed ID: 26307902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved Beta Cell Glucose Sensitivity Plays Predominant Role in the Decrease in HbA1c with Cana and Lira in T2DM.
    Ali AM; Mari A; Martinez R; Al-Jobori H; Adams J; Triplitt C; DeFronzo R; Cersosimo E; Abdul-Ghani M
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32745202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dapagliflozin lowers plasma glucose concentration and improves β-cell function.
    Merovci A; Mari A; Solis-Herrera C; Xiong J; Daniele G; Chavez-Velazquez A; Tripathy D; Urban McCarthy S; Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2015 May; 100(5):1927-32. PubMed ID: 25710563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.
    Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staged diabetes management according to individual patient insulin resistance and beta-cell function ameliorates glycaemic control in type 2 diabetes mellitus.
    Choi SH; Hur KY; Kim DJ; Ahn CW; Kang ES; Cha BS; Lim SK; Huh KB; Lee HC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):549-55. PubMed ID: 18248646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.
    Bellia A; Rizza S; Lombardo MF; Donadel G; Fabiano R; Andreadi K; Quon MJ; Sbraccia P; Federici M; Tesauro M; Cardillo C; Lauro D
    Atherosclerosis; 2012 Jul; 223(1):197-203. PubMed ID: 22658255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy.
    Cheng Q; Yang S; Zhao C; Wang Z; Feng Z; Li R; Ye P; Zhang S; Deng H; Zhou B; Long J; Gong L; Qing H; Luo C; Li Q
    J Diabetes; 2015 Mar; 7(2):182-91. PubMed ID: 24823280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in early-phase insulin secretion and glucose disposition index between aged and middle-aged patients with newly diagnosed type 2 diabetes.
    Yu Y; Pan F; Cui W; Tang W; Hu Y
    Geriatr Gerontol Int; 2020 Mar; 20(3):206-211. PubMed ID: 31923347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.
    Roy Chowdhury S; Thomas RL; Dunseath GJ; Peter R; Rees DA; North RV; Luzio SD; Owens DR
    J Clin Endocrinol Metab; 2016 Feb; 101(2):572-80. PubMed ID: 26652932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding glucose-lowering agents delays insulin initiation and prolongs hyperglycemia.
    Hugie C; Waterbury NV; Alexander B; Shaw RF; Egge JA
    Am J Manag Care; 2016 Apr; 22(4):e134-40. PubMed ID: 27143349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity.
    Arnetz L; Hage C; Ekberg NR; Alvarsson M; Brismar K; Norhammar A; Mellbin L
    Growth Horm IGF Res; 2015 Dec; 25(6):298-303. PubMed ID: 26283275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial hyperglycaemia--its importance and implications.
    Lüddeke HJ
    Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients.
    Chon S; Oh S; Kim SW; Kim JW; Kim YS; Woo JT
    Korean J Intern Med; 2010 Sep; 25(3):273-81. PubMed ID: 20830224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.
    Kim KS; Oh DH; Kim JY; Lee BG; You JS; Chang KJ; Chung HJ; Yoo MC; Yang HI; Kang JH; Hwang YC; Ahn KJ; Chung HY; Jeong IK
    Exp Mol Med; 2012 Nov; 44(11):665-73. PubMed ID: 23114424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.